CELLDEX THERAPEUTICS INC NEW - COM (CLDX)

CUSIP: 15117B103

Q2 2015 13F Holders as of 30 Jun 2015

Type / Class
Equity / COM
Total 13F shares
86,637,747
Share change
-685,234
Total reported value
$2,185,000,511
Put/Call ratio
149%
Price per share
$25.22
Number of holders
184
Value change
-$25,013,337
Number of buys
96
Number of sells
85

Quarterly Holders Quick Answers

What is CUSIP 15117B103?
CUSIP 15117B103 identifies CLDX - CELLDEX THERAPEUTICS INC NEW - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of CELLDEX THERAPEUTICS INC NEW - COM (CLDX) as of Q2 2015

As of 30 Jun 2015, CELLDEX THERAPEUTICS INC NEW - COM (CLDX) was held by 184 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 86,637,747 shares. The largest 10 holders included FMR LLC, OPPENHEIMER FUNDS INC, FRANKLIN RESOURCES INC, VANGUARD GROUP INC, FIRST TRUST ADVISORS LP, BlackRock Fund Advisors, STATE STREET CORP, COLUMBIA WANGER ASSET MANAGEMENT LLC, FRONTIER CAPITAL MANAGEMENT CO LLC, and BlackRock Institutional Trust Company, N.A.. This page lists 184 institutional shareholders reporting positions in this security for the Q2 2015 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.